Established in 2013, represents a consortium of experts addressing sarcopenia’s increasing prevalence among Asian populations. Sarcopenia comprises a progressive decline in skeletal muscle mass, strength, and function, correlating with elevated morbidity, mortality, and diminished quality of life.

The AWGS formulates region-specific guidelines that account for Asia’s distinct demographic composition, genetic profiles, cultural characteristics, and healthcare systems. Following their inaugural consensus on diagnostic criteria in 2014, the group published revised guidelines in 2020.